Company Filing History:
Years Active: 2017-2025
Title: Glenn Crater: Innovator in Pharmaceutical Compositions
Introduction
Glenn Crater is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for inhaled administration.
Latest Patents
Glenn Crater holds 3 patents that focus on combinations of muscarinic receptor antagonists and β-2 adrenoreceptor agonists. His latest patents include methods for using these combinations for inhaled administration via the nose or mouth. These compositions aim to enhance therapeutic efficacy and patient compliance.
Career Highlights
Glenn Crater has established himself as a key figure in the pharmaceutical industry. He works at Glaxo Group Limited, where he continues to innovate and develop new therapeutic solutions. His work has the potential to improve treatment options for various respiratory conditions.
Collaborations
Glenn collaborates with talented individuals such as Darrell Baker and Mark Bruce. Their combined expertise contributes to the advancement of pharmaceutical research and development.
Conclusion
Glenn Crater's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight the importance of developing effective treatments for patients.